Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Clinical trial NCT06375239 · RECRUITING

Trial details

NCT number: NCT06375239
Sponsor: Ray Therapeutics, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Retinitis Pigmentosa Choroideremia Stargardt Macular Dystrophy Stargardt Disease Geographic Atrophy from Age-related Macular Degeneration X-lined Retinoschisis Retinal Dystrophies

Start date: 2024-04-05
Primary completion: 2026-04-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.